359
We describe a 52-year-old male diagnosed with stage III multiple myeloma, who was treated with 5-monthly cycles of VAD (vincristine, adriamycin and dexamathasone).
 a 52-year-old male: Subject; 52-year-old: Subject.Age; male: Subject.Gender; 5-monthly cycles of VAD (vincristine, adriamycin and dexamathasone): Treatment; stage III multiple myeloma: Treatment.Disorder; 5-monthly: Treatment.Duration; vincristine: Treatment.Drug; adriamycin: Treatment.Drug; dexamathasone: Treatment.Drug; vincristine: Combination.Drug; adriamycin: Combination.Drug; dexamathasone: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: potential therapeutic event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Treatment.Time_elapsed, Subject.Disorder, Subject.Race, Treatment.Route, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a 52-year-old male: Subject; 52-year-old: Subject.Age; male: Subject.Gender; 5-monthly cycles of VAD (vincristine, adriamycin and dexamathasone): Treatment; stage III multiple myeloma: Treatment.Disorder; 5-monthly: Treatment.Duration; vincristine: Treatment.Drug; adriamycin: Treatment.Drug; dexamathasone: Treatment.Drug; vincristine: Combination.Drug; adriamycin: Combination.Drug; dexamathasone: Combination.Drug